<DOC>
	<DOCNO>NCT01724892</DOCNO>
	<brief_summary>Corticosteroid use treatment phototherapeutic keratectomy ( PRK ) . Dexamethasone , potent steroid retard corneal epithelial healing rate numerous serious complication , especially glaucoma . Loteprednol , new generation corticosteroid less potency dexamethasone propose less side effect regard intraocular pressure ( IOP ) elevation . Therefore , Investigators would like compare effect dexamethasone loteprednol corneal epithelial healing rate PRK risk glaucoma .</brief_summary>
	<brief_title>Comparison Effects Dexamethasone Loteprednol Epithelial Healing</brief_title>
	<detailed_description />
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Loteprednol Etabonate</mesh_term>
	<criteria>patient epithelial defect phototherapeutic keratectomy patient systemic disease diabetes connective tissue disease patient ocular surface disease dry eye recurrent corneal erosion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>